Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Polymorphisms in DNA repair genes and risk of glioma and meningioma.

Luo KQ, Mu SQ, Wu ZX, Shi YN, Peng JC.

Asian Pac J Cancer Prev. 2013;14(1):449-52.

2.

XRCC1 and XRCC3 variants and risk of glioma and meningioma.

Kiuru A, Lindholm C, Heinävaara S, Ilus T, Jokinen P, Haapasalo H, Salminen T, Christensen HC, Feychting M, Johansen C, Lönn S, Malmer B, Schoemaker MJ, Swerdlow AJ, Auvinen A.

J Neurooncol. 2008 Jun;88(2):135-42. doi: 10.1007/s11060-008-9556-y.

PMID:
18330515
3.

Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk.

El-Zein R, Monroy CM, Etzel CJ, Cortes AC, Xing Y, Collier AL, Strom SS.

Cancer. 2009 Apr 15;115(8):1651-9. doi: 10.1002/cncr.24205.

4.

DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma.

Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, Selker RG, Shapiro WR, Rothman N, Linet MS, Inskip PD.

Neuro Oncol. 2010 Jan;12(1):37-48. doi: 10.1093/neuonc/nop012. Epub 2009 Dec 10.

5.

Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.

Lu B, Li J, Gao Q, Yu W, Yang Q, Li X.

Gene. 2014 May 25;542(1):64-8. doi: 10.1016/j.gene.2014.02.043. Epub 2014 Feb 26.

PMID:
24582975
6.

Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.

Liu R, Zhao X, Liu X, Chen Z, Qiu L, Geng R, Guo W, He G, Yin J, Li J, Zhu X.

Tumour Biol. 2016 Feb;37(2):1753-62. doi: 10.1007/s13277-015-3935-8. Epub 2015 Aug 28.

PMID:
26314858
7.

Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.

Wu JS, Chen YP, Wang LC, Yang YJ, Deng CW, Hou BX, He ZL, Chen JX.

Genet Mol Res. 2014 May 16;13(2):3812-8. doi: 10.4238/2014.May.16.5.

8.

Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain.

López-Cima MF, González-Arriaga P, García-Castro L, Pascual T, Marrón MG, Puente XS, Tardón A.

BMC Cancer. 2007 Aug 16;7:162.

9.

Investigation of the effects of single-nucleotide polymorphisms in DNA repair genes on the risk of glioma.

Gao K, Mu SQ, Wu ZX.

Genet Mol Res. 2014 Feb 27;13(1):1203-11. doi: 10.4238/2014.February.27.5.

10.

Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.

Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A.

Carcinogenesis. 2006 Mar;27(3):560-7. Epub 2005 Sep 29.

PMID:
16195237
11.

An association of selected ERCC2 and ERCC5 genes polymorphisms, the level of oxidative DNA damage and its repair efficiency with a risk of colorectal cancer in Polish population.

Kabzinski J, Przybylowska K, Dziki L, Dziki A, Majsterek I.

Cancer Biomark. 2015;15(4):413-23. doi: 10.3233/CBM-150488.

PMID:
25835182
12.

Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.

Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G, Traficante A, Cittadini A.

Anticancer Res. 2008 Sep-Oct;28(5B):2941-6.

13.

Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.

Qian T, Zhang B, Qian C, He Y, Li Y.

Medicine (Baltimore). 2017 May;96(20):e6832. doi: 10.1097/MD.0000000000006832. Review.

14.

Polymorphisms in DNA repair genes and susceptibility to glioma in a chinese population.

Pan WR, Li G, Guan JH.

Int J Mol Sci. 2013 Feb 5;14(2):3314-24. doi: 10.3390/ijms14023314.

15.

Single nucleotide polymorphisms in DNA repair genes and the risk of laryngeal cancer: A meta-analysis.

Li F, Wang J, Chen M.

Biomed Pharmacother. 2016 Mar;78:92-100. doi: 10.1016/j.biopha.2015.12.019. Epub 2016 Jan 21.

PMID:
26898429
16.

Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk.

Ming-Shiean H, Yu JC, Wang HW, Chen ST, Hsiung CN, Ding SL, Wu PE, Shen CY, Cheng CW.

Ann Surg Oncol. 2010 Mar;17(3):760-71.

PMID:
20183911
17.

Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma.

Yan L, Li Q, Li X, Ji H, Zhang L.

Cell Physiol Biochem. 2016;38(3):1075-84. doi: 10.1159/000443058. Epub 2016 Mar 4.

18.

The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myeloblastic leukemia.

Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E.

Blood. 2002 Nov 15;100(10):3761-6. Epub 2002 Jul 18.

19.

DNA repair gene polymorphisms and risk of head and neck cancer in the Tunisian population.

Khlifi R, Kallel I, Hammami B, Hamza-Chaffai A, Rebai A.

J Oral Pathol Med. 2014 Mar;43(3):217-24. doi: 10.1111/jop.12114. Epub 2013 Sep 11.

PMID:
24020925
20.

Susceptibility of XRCC3, XPD, and XPG genetic variants to cervical carcinoma.

He X, Ye F, Zhang J, Cheng Q, Shen J, Chen H.

Pathobiology. 2008;75(6):356-63. doi: 10.1159/000164220. Epub 2008 Dec 15.

Supplemental Content

Support Center